Ecuador Medical Device Registration 2026: Permiso de Funcionamiento and Establishment Licensing

Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

The operating permit (permiso de funcionamiento) is an establishment obligation, not a product obligation: Article 60 provides that establishments engaged in the manufacture, import, distribution, storage or commercialization of medical devices and in vitro diagnostic reagents must hold a valid operating permit issued by ARCSA and may only carry out the activities expressly stated in the permit document. Establishments engaged in manufacturing and importing must additionally place technical responsibility with a pharmaceutical chemist or a biochemical pharmaceutical chemist, whose degree must be registered with SENESCYT and recorded with ACESS. The permit sits upstream of every registration action a company takes in Ecuador, because the same establishment details reappear on the application form and must remain aligned throughout the review.

2. Legal basis

RegulationReference numberPublication dateArticle provisions
Substitute Technical Sanitary Regulation for the Registration, Control and Surveillance of Medical Devices for Human UseResolución ARCSA-DE-2026-003-DASPSigned 2026-04-28Article 60 (operating permit and technical director)
Same regulationSameSameArticle 23(a) (declaration of the permit number at filing), transitory general provision seven
Same regulationSameSameArticle 61 (system certificates for domestic manufacturers), Articles 62 to 63 (ISO 13485 registration)
Health LawLey 67/2006, Registro Oficial Suplemento 4232006-12-22Article 134 (legal basis of the operating permit)

3. Expert insights

Insight 1: Article 60 lists five activities and confines the holder to the activities stated in the permit. Manufacturing, import, distribution, storage and commercialization: a permit holder that only holds a distribution permit but carries out importation is operating outside the permitted scope. This is the single most important point to check when vetting the qualifications of a channel partner, because out-of-scope activity exposes the whole supply chain, including the registrations distributed through that channel, to regulatory findings. The activity categories are printed on the permit document itself, so the check is documentary rather than declaratory.

Insight 2: The technical director qualification is a hard threshold, and it applies only to manufacturing and import. The second sentence of Article 60 provides that for manufacturing and import activities, technical responsibility must be borne by a pharmaceutical chemist or a biochemical pharmaceutical chemist, whose professional degree must be registered with SENESCYT or the corresponding body, and recorded with the national health authority through ACESS or the corresponding body. Distribution-only establishments are not required to engage such a professional, which makes the staffing profile of a partner a reliable indicator of what it is actually licensed to do.

Insight 3: Transitory general provision seven ties the operating permit to the submission information. The applicant information declared in the VUE system must match the information in the operating permit and the activities to be undertaken. This creates a three-way consistency requirement across the permit, the submission and the actual activity.

Insight 4: The operating permit number is a mandatory declaration item on the application form. Article 23(a) requires that the operating permit number (valid) be the first item of information declared at the time of application. An expired permit leads directly to the return of the application. Because review periods and deficiency responses run while the permit must stay alive, a permit that expires mid-review creates exactly the kind of avoidable failure that the single-deficiency-response rule does not forgive.

Insight 5: The split between domestic and imported products on system certificates runs parallel to the operating permit. Article 61 requires domestic manufacturing establishments to hold a BPM or ISO 13485 certificate issued by ARCSA, by a body recognized by SAE, or by an agency designated by MPCEI; Articles 62 and 63 provide that ISO 13485 certification on the domestic pathway must be registered with ARCSA. The operating permit and the system certificate are two independent obligations. A manufacturer entering the domestic pathway therefore faces both a site-level permit track and a system-level certificate track, and neither one advances the other, so the two should be scheduled in parallel from the outset.

Insight 6: The reform provisions amend the definitions of the regulations governing operating permits. Reform provision six (SEXTA) of the new regulation adds to the definitions section of Resolución ARCSA-DE-2023-001-AKRG (Registro Oficial No. 238, 2023-01-26, the technical sanitary regulation for issuing operating permits to establishments subject to health surveillance and inspection) the definition of professional related to medical devices (Profesional afín a dispositivos médicos). This confirms that the operating permit framework itself is being updated in step with the new device regulation, and that staffing and qualification terms should be checked against the amended definitions rather than against older commentaries.

4. Practical recommendations

  1. Compare the activity categories line by line when verifying a holder’s operating permit, and confirm that import and distribution are both covered.
  2. Confirm that the technical director’s SENESCYT registration and ACESS recording are current, and retain documentary evidence.
  3. Keep a permit validity ledger, so that the permit remains valid throughout the entire submission and review cycle, including any deficiency response periods.
  4. Cross-check the VUE declaration fields against the operating permit field by field, to avoid triggering transitory general provision seven.
  5. Plan system certificates and ISO 13485 registration separately on the domestic pathway, and manage them independently of the operating permit.

5. Verification checklist

  • □ The holder’s operating permit is valid and its activity scope covers import and distribution
  • □ The technical director is a pharmaceutical chemist or a biochemical pharmaceutical chemist
  • □ The technical director’s degree is registered with SENESCYT and recorded with ACESS
  • □ The operating permit number has been entered correctly on the application form (Article 23(a))
  • □ The VUE declaration has been cross-checked against the operating permit field by field
  • □ System certificates and ISO 13485 registration have been planned separately on the domestic pathway

Regulatory information verified as of October 29, 2026

GRZAN service note

GRZAN provides regulatory support in this country for medical device manufacturers, importers and authorized representatives, covering registration pathway planning, operating permit verification and licensing structure design, technical director qualification checks, official fee and timeline estimation, technical dossier preparation, and post-market compliance management. Manufacturers and importers vetting an Ecuador channel partner or preparing a submission may contact GRZAN at info@grzanglobal.com for a tailored solution.

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail